FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Pfeilstöcker

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Julie Schanz; Marilyn L Slovak; Francesc Solé; Reinhard Stauder; Christian Steidl; Heinz Tüchler; Peter Valent; Carlo Aul; John M Bennett; José Cervera; Stefan Faderl; Christa Fonatsch; Guillermo Garcia-Manero; Ulrich Germing; Aristoteles Giagounidis; Isabel Granada; Peter Greenberg; Barbara Hildebrandt; Otto Krieger; Michelle M Le Beau; Michael Lübbert; Elisa Luño; Mar Mallo; Thomas Nösslinger; Kazuma Ohyashiki; Michael Pfeilstöcker; Sherry Pierce; Detlef Haase
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
Julie Schanz; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Heinz Tuechler; Peter Valent; Barbara Hildebrandt; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Hagop Kantarjian; Ulrich Germing; Detlef Haase; Elihu Estey
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
Pierre Fenaux; David Bowen; Norbert Gattermann; Eva Hellström-Lindberg; Wolf-Karsten Hofmann; Michael Pfeilstöcker; Guillermo Sanz; Valeria Santini
Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Pfeilstöcker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Julie Schanz; Marilyn L Slovak; Francesc Solé; Reinhard Stauder; Christian Steidl; Heinz Tüchler; Peter Valent; Carlo Aul; John M Bennett; José Cervera; Stefan Faderl; Christa Fonatsch; Guillermo Garcia-Manero; Ulrich Germing; Aristoteles Giagounidis; Isabel Granada; Peter Greenberg; Barbara Hildebrandt; Otto Krieger; Michelle M Le Beau; Michael Lübbert; Elisa Luño; Mar Mallo; Thomas Nösslinger; Kazuma Ohyashiki; Michael Pfeilstöcker; Sherry Pierce; Detlef Haase
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):820-9.
2011: Julie Schanz; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Heinz Tuechler; Peter Valent; Barbara Hildebrandt; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Hagop Kantarjian; Ulrich Germing; Detlef Haase; Elihu Estey
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):1963-70.
2010: Pierre Fenaux; David Bowen; Norbert Gattermann; Eva Hellström-Lindberg; Wolf-Karsten Hofmann; Michael Pfeilstöcker; Guillermo Sanz; Valeria Santini
Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.
Leukemia research 2010;34(11):1410-6.
2010: Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
[Tumor stem cell research - basis and challenge for diagnosis and therapy].
Wiener klinische Wochenschrift 2010;122(13-14):423-36.
2010: Thomas Nösslinger; Heinz Tüchler; Ulrich Germing; Wolfgang R Sperr; O Krieger; Detlef Haase; Michael Lübbert; R Stauder; A Giagounidis; P Valent; Michael Pfeilstöcker
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):120-5.
2010: Wolfgang R Sperr; Friedrich Wimazal; Michael Kundi; Christian Baumgartner; Thomas Nösslinger; A Makrai; Reinhard Stauder; Otto Krieger; Michael Pfeilstöcker; Peter Valent
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):114-9.
2009: Peter Valent; Wolf-Karsten Hofmann; Guntram Büsche; Karl Sotlar; Hans-Peter Horny; Detlef Haase; Torsten Haferlach; Wolfgang Kern; Peter Bettelheim; Christian Baumgartner; Wolfgang R Sperr; Thomas Nösslinger; Friedrich Wimazal; Aristoteles A Giagounidis; Michael Lübbert; Otto Krieger; Hans-Jochem Kolb; Reinhard Stauder; Michael Pfeilstöcker; Norbert Gattermann; Christa Fonatsch; Carlo Aul; Ulrich Germing
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
Annals of hematology 2009;88(7):607-11.
2009: Friedrich Wimazal; Thomas Nösslinger; Christoph Baumgartner; Wolfgang R Sperr; Michael Pfeilstöcker; Peter Valent
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes.
European journal of clinical investigation 2009;39(5):406-11.
2009: Michael Handschur; Heidrun Karlic; Christian Hertel; Michael Pfeilstöcker; Alexander G Haslberger
Preanalytic removal of human DNA eliminates false signals in general 16S rDNA PCR monitoring of bacterial pathogens in blood.
Comparative immunology, microbiology and infectious diseases 2009;32(3):207-19.
2008: Reinhard Stauder; Thomas Nösslinger; Michael Pfeilstöcker; Wolfgang R Sperr; Friedrich Wimazal; Otto Krieger; Peter Valent
Impact of age and comorbidity in myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):927-34.
2008: Peter Valent; Otto Krieger; Reinhard Stauder; Friedrich Wimazal; Thomas Nösslinger; Wolfgang R Sperr; H Sill; P Bettelheim; Michael Pfeilstöcker
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.
European journal of clinical investigation 2008;38(3):143-9.
2008: Peter Wihlidal; Heidrun Karlic; Michael Pfeilstöcker; Klaus Klaushofer; Franz Varga
Imatinib mesylate (IM)-induced growth inhibition is associated with production of spliced osteocalcin-mRNA in cell lines.
Leukemia research 2008;32(3):437-43.
2008: Reinhard Stauder; Friedrich Wimazal; Thomas Nösslinger; Otto Krieger; Wolfgang R Sperr; Heinz Sill; Michael Pfeilstöcker; Peter Valent
[Individualized management and therapy of myelodysplastic syndromes].
Wiener klinische Wochenschrift 2008;120(17-18):523-37.
2008: Hannes Kaufmann; Jutta Ackermann; V Odelga; Verena Sagaster; Thomas Nösslinger; Michael Pfeilstöcker; A Keck; Heinz Ludwig; Heinz Gisslinger; Johannes Drach
Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.
European journal of clinical investigation 2008;38(1):53-60.
2008: Christian Sillaber; Matthias Mayerhofer; Alexandra Böhm; Anja Vales; Alexander Gruze; Karl J Aichberger; Harald Esterbauer; Michael Pfeilstöcker; Wolfgang R Sperr; Winfried F Pickl; Oskar A Haas; Peter Valent
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
European journal of clinical investigation 2008;38(1):43-52.
2007: Detlef Haase; Ulrich Germing; Julie Schanz; Michael Pfeilstöcker; Thomas Nösslinger; Barbara Hildebrandt; Andrea Kundgen; Michael Lübbert; Regina Kunzmann; Aristoteles Giagounidis; Carlo Aul; Lorenz Trümper; Otto Krieger; Reinhard Stauder; Thomas H Müller; Friedrich Wimazal; Peter Valent; Christa Fonatsch; Christian Steidl
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.
Blood 2007;110(13):4385-95.
2007: Michael Pfeilstöcker; Heidrun Karlic; Thomas Nösslinger; Wolfgang Sperr; Reinhard Stauder; Otto Krieger; Peter Valent
Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.
Leukemia & lymphoma 2007;48(10):1900-9.
2007: Peter Valent; Hans-Peter Horny; John M Bennett; Christa Fonatsch; Ulrich Germing; Peter Greenberg; Torsten Haferlach; Detlef Haase; Hans-Jochen Kolb; Otto Krieger; Michael R Loken; Arjan van de Loosdrecht; Kiyoyuki Ogata; Alberto Orfao; Michael Pfeilstöcker; Björn Rüter; Wolfgang R Sperr; Reinhard Stauder; Denise A Wells
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
Leukemia research 2007;31(6):727-36.
2006: Peter Wihlidal; Franz Varga; Michael Pfeilstöcker; Heidrun Karlic
Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
Leukemia research 2006;30(10):1241-8.
2006: Michael Fillitz; Heidrun Karlic; Heinz Tüchler; Johannes Zeibig; Wolfgang Spiegel; Peter Wihlidal; Franz Varga; Elisabeth Pittermann; Michael Pfeilstöcker
Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?
Annals of hematology 2006;85(6):386-93.
2005: Ulrich Germing; Barbara Hildebrandt; Michael Pfeilstöcker; Thomas Nösslinger; Peter Valent; Christa Fonatsch; Michael Lübbert; Detlef Haase; Christian Steidl; Otto Krieger; Reinhard Stauder; Aristoteles Giagounidis; Corinna Strupp; Andrea Kündgen; T Mueller; Rainer Haas; Norbert Gattermann; Carlo Aul
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).
Leukemia 2005;19(12):2223-31.
2005: Albert Wölfler; Stefan J Erkeland; Claudia Bodner; Marijke Valkhof; Wilfried Renner; Christina Leitner; Werner Olipitz; Michael Pfeilstöcker; Christoph Tinchon; Werner Emberger; Werner Linkesch; Ivo P Touw; Heinz Sill
A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome.
Blood 2005;105(9):3731-6.
2004: Hannes Kaufmann; Jutta Ackermann; C Baldia; Thomas Nösslinger; Rotraud Wieser; Sonja Seidl; Verena Sagaster; Heinz Gisslinger; Ulrich Jäger; Michael Pfeilstöcker; Christoph Zielinski; Johannes Drach
Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Leukemia 2004;18(11):1879-82.
2003: Heidrun Karlic; Alfred Lohninger; Claudia Laschan; Alexander Lapin; Franz Böhmer; Marlies Huemer; Elisabeth Guthann; Eduard Rappold; Michael Pfeilstöcker
Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes.
Journal of molecular medicine (Berlin, Germany) 2003;81(7):435-42.
2002: Michael Pfeilstöcker; Heidrun Karlic; Thomas Nösslinger; Heinz Tüchler; Alfred Lohninger; Elisabeth Pittermann
Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Galpha16 and 5'-lipoxygenase.
Annals of hematology 2002;81(11):632-40.
2001: Thomas Nösslinger; Regina Reisner; E Koller; Helga Grüner; Heinz Tüchler; H Nowotny; Elisabeth Pittermann; Michael Pfeilstöcker
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.
Blood 2001;98(10):2935-41.
2001: Thomas Nösslinger; Regina Reisner; Helga Grüner; Heinz Tüchler; H Nowotny; Elisabeth Pittermann; Michael Pfeilstöcker
Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.
Leukemia research 2001;25(9):741-7.
2001: Heidrun Karlic; Norbert Louda; Michael Pfeilstöcker; Felix Keil; Alfred Lohninger; Elisabeth Pittermann; J Paukovits
Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Stem cells (Dayton, Ohio) 2001;19(4):321-8.
2000: Michael Pfeilstöcker; Heidrun Karlic; J Salamon; Helmut Mühlberger; Borislava G Pavlova; H Strobl; Elisabeth Pittermann; R Heinz
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34.
American journal of hematology 2000;64(3):156-60.
1999: Michael Pfeilstöcker; Regina Reisner; Thomas Nösslinger; Helga Grüner; H Nowotny; Heinz Tüchler; E Schlögl; Elisabeth Pittermann; R Heinz
Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.
British journal of haematology 1999;106(2):455-63.
1999: Michael Pfeilstöcker; Heidrun Karlic; J Paukovits; G Anzenberger; Norbert Louda; J Salamon; Helmut Mühlberger; H Strobl; Elisabeth Pittermann; R Heinz
In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
Leukemia 1999;13(4):590-4.
1998: Michael Pfeilstöcker; Heidrun Karlic; J Salamon; Helmut Mühlberger; Borislava G Pavlova; U Selim; H Strobl; Elisabeth Pittermann; R Heinz
Monitoring of hematopoietic recovery after autologous stem cell transplantation by analysis of G alpha 16 mRNA and CD34 surface glycoprotein.
Annals of hematology 1998;76(3-4):153-8.
1997: Heidrun Karlic; M Möstl; H Mucke; Borislava G Pavlova; Michael Pfeilstöcker; R Heinz
Association of human T-cell leukemia virus and myelodysplastic syndrome in a central European population.
Cancer research 1997;57(21):4718-21.
1996: Michael Pfeilstöcker; Heidrun Karlic; J Salamon; Elisabeth Krömer; Helmut Mühlberger; Borislava G Pavlova; U Selim; Heinz Tüchler; G Fritsch; S Kneissl; R Heinz; E Pitterman; M R Paukovits
Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia.
Leukemia 1996;10(7):1117-21.
1996: G Hopfinger; R Heinz; Michael Pfeilstöcker; E Schlögl; R Waldner; Elisabeth Pittermann
Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):423-4.
1995: Michael Pfeilstöcker; R Grill; E Koller; O Krieger; Elisabeth Pittermann; Heidrun Karlic
FMS hemizygosity in myeloid dysplasia and acute myeloid leukemia with chromosomal aberration del(5)(q) demonstrated by polymerase chain reaction.
Journal of molecular medicine (Berlin, Germany) 1995;73(8):403-7.
1995: Michael Pfeilstöcker; R Waldner; R Reisner; R Heinz; Elisabeth Pittermann
[Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia].
Infusionstherapie und Transfusionsmedizin 1995;22(4):220-4.
1995: Heidrun Karlic; Helmut Mühlberger; Borislava G Pavlova; Michael Pfeilstöcker; J Salamon; Elisabeth Pittermann; R Heinz; E Koller
Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemia.
Bone marrow transplantation 1995;15(6):999-1000.